Class II recall: Baxter Healthcare Corporation: Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Cont

Baxter Healthcare Corporation has issued a Class II recall of Nexterone (amiodarone HCl), 360 mg/200 mL (1.8 mg/mL), supplied in GALAXY Single-Dose Containers, NDC 43066-360-20. The recall was initiated due to current good manufacturing practice (CGMP) deviations, according to the recall notice. The product is a sterile, nonpyrogenic, iso-osmotic solution in dextrose manufactured in the USA.

Most relevant for: patients receiving intravenous amiodarone for cardiac arrhythmia management who may have received affected Nexterone batches from this recall

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.